Pay in 4 interest-free payments of $6.05 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
FDA warning against unapproved GLP-1 drugs for weight loss The official website of FDA clearly states that unapproved versions of GLP-1 (glucagon-like peptide-1 (GLP-1) receptor agonists) drugs can be risky for patients
By identifying and titrating at the patients pace , we can improve tolerability
View Study [3]"Prospective, randomized, controlled, proof-of-concept study of the Ghrelin mimetic ipamorelin for the management of postoperative ileus in bowel resection patients" Beck DE, Sweeney WB, McCarter MD, et al., 2014 Finding: This Phase 2 randomized controlled trial in 117 surgery patients showed Ipamorelin was well-tolerated with no significant safety concerns compared to placebo
(49.9% and 45.6%, respectively)
